Portalvein reconstruction with a cadaveric descending thoracic aortic homograft.
Publication/Presentation Date
6-1-2022
Abstract
Improvements in chemoradiotherapy have rendered complex pancreatic cancers involving the portal vein (PV) amenable to resection. PV reconstruction (PVR) is an essential component. Various conduits have been proposed; however, the optimal choice remains unknown. Fourteen patients underwent PVR with a cadaveric descending thoracic aortic homograft from 2014 to 2020. The primary diagnosis was pancreatic cancer. The splenic vein was ligated in seven patients (50%). The 30-day and 3-, 12-, and 24-month primary patency rates were 100%, 86%, 76%, and 76%, respectively. We found a cadaveric descending thoracic aortic homograft is an excellent conduit for PVR, given the optimal size, rapidly availability, favorable risk profile, and absence of harvest site complications.
Volume
8
Issue
2
First Page
294
Last Page
297
ISSN
2468-4287
Published In/Presented At
Gaffey, A. C., Zhang, J., Lee, M. K., Roses, R., Jackson, B. M., & Quatromoni, J. G. (2022). Portalvein reconstruction with a cadaveric descending thoracic aortic homograft. Journal of vascular surgery cases and innovative techniques, 8(2), 294–297. https://doi.org/10.1016/j.jvscit.2022.04.001
Disciplines
Medicine and Health Sciences
PubMedID
35647419
Department(s)
Department of Medicine, Cardiology Division
Document Type
Article